# 2026-10189: FDA Extends Paperwork for Animal Drug Side Effects

2026-10189, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Experience/Events With Approved New Animal Drugs, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-21, effective Submit written comments (including recommendations) on the collection of information by June 22, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-10189
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-10189
- Title: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Adverse Experience/Events With Approved New Animal Drugs
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 29966
- Published: 2026-05-21
- Effective: Submit written comments (including recommendations) on the collection of information by June 22, 2026.
- Comments close: 2026-06-22
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Extends Paperwork for Animal Drug Side Effects

## Summary

The FDA is asking for approval to keep collecting info about problems with approved new animal drugs, like side effects or manufacturing issues. This helps make sure animal medicines stay safe and effective. Drug companies need to keep reporting these issues, and the public can comment until June 22, 2026. There’s no new cost, just a continuation of current rules.

## Abstract

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

## Effects PRIA read

- Adverse-event reporting stays required: cost, medium. If you make or hold an approved new animal drug application, you must keep submitting adverse event and product/manufacturing defect reports under section 512(l) and 21 CFR 514.80 using Forms FDA 1932, 1932a, and 2301. The collection continues under OMB Control Number 0910-0284 and is a continuatio…
- Estimated reporting and recordkeeping burden rose: cost, high. FDA estimates the collection now requires about 139,561 annual reporting responses taking 194,349.5 hours and about 124,443 recordkeeping records taking 1,742,132 hours. FDA says its estimate reflects an overall increase of 22,073.50 hours and 15,117 responses due to more submissions in recent year…
- Limited waivers allowed for electronic filing: benefit, low. FDA requires electronic submission of postmarketing safety reports under Sec. 514.80 but allows a temporary waiver on a limited basis for good cause. An initial waiver request may be made by telephone or email to CVM's Division of Pharmacovigilance and Surveillance, followed promptly by a written l…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-10189 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/21/2026-10189/agency-information-collection-activities-submission-for-office-of-management-and-budget-review)
- [2026-10189 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-21/pdf/2026-10189.pdf)

## Related
- [Previous: 2026-10188, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-10188)
- [Next: 2026-10190, Agency Information Collection Activities; Submission for Office of Management a…](https://policyrisk.com/federal-register/2026-10190)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-10189 (as of 2026-06-08).
